Blueprint Medicines Corp (BPMC)
94.15
-2.47
(-2.56%)
USD |
NASDAQ |
Nov 22, 16:00
94.20
+0.05
(+0.05%)
After-Hours: 20:00
Blueprint Medicines Price to Book Value: 19.10 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 19.10 |
| November 21, 2024 | 19.60 |
| November 20, 2024 | 19.23 |
| November 19, 2024 | 19.19 |
| November 18, 2024 | 18.29 |
| November 15, 2024 | 17.99 |
| November 14, 2024 | 19.40 |
| November 13, 2024 | 19.65 |
| November 12, 2024 | 19.60 |
| November 11, 2024 | 20.26 |
| November 08, 2024 | 20.45 |
| November 07, 2024 | 20.57 |
| November 06, 2024 | 20.21 |
| November 05, 2024 | 19.79 |
| November 04, 2024 | 18.64 |
| November 01, 2024 | 18.40 |
| October 31, 2024 | 17.75 |
| October 30, 2024 | 18.10 |
| October 29, 2024 | 16.92 |
| October 28, 2024 | 16.79 |
| October 25, 2024 | 16.71 |
| October 24, 2024 | 16.84 |
| October 23, 2024 | 17.10 |
| October 22, 2024 | 17.52 |
| October 21, 2024 | 17.35 |
| Date | Value |
|---|---|
| October 18, 2024 | 17.43 |
| October 17, 2024 | 17.43 |
| October 16, 2024 | 18.10 |
| October 15, 2024 | 18.07 |
| October 14, 2024 | 17.96 |
| October 11, 2024 | 18.00 |
| October 10, 2024 | 17.62 |
| October 09, 2024 | 17.75 |
| October 08, 2024 | 17.73 |
| October 07, 2024 | 18.10 |
| October 04, 2024 | 17.96 |
| October 03, 2024 | 17.85 |
| October 02, 2024 | 18.39 |
| October 01, 2024 | 18.24 |
| September 30, 2024 | 18.74 |
| September 27, 2024 | 18.31 |
| September 26, 2024 | 17.62 |
| September 25, 2024 | 17.21 |
| September 24, 2024 | 17.86 |
| September 23, 2024 | 17.81 |
| September 20, 2024 | 18.13 |
| September 19, 2024 | 17.99 |
| September 18, 2024 | 17.67 |
| September 17, 2024 | 17.11 |
| September 16, 2024 | 17.07 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.056
Minimum
Jun 13 2022
46.78
Maximum
Feb 27 2024
9.784
Average
5.563
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.262 |
| Regeneron Pharmaceuticals Inc | 2.765 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
Price to Book Value Related Metrics
| PS Ratio | 13.60 |
| Price | 94.15 |
| Earnings Yield | -2.24% |
| Market Cap | 5.981B |